Screener
Travere Therapeutics, Inc. TVTX Total debt
Total debt at other companies
Other financials
Where this comes from
Computed from long term debt + current portion long term debt + short term borrowings + operating lease liabilities + finance lease liabilities + financing obligations: $15.58M.
The source filing: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026. Open the filing →
- Filed
- May 4, 2026, 4:45 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001438533-26-000042
FAQ
- What is Travere Therapeutics, Inc.'s total debt?
- Travere Therapeutics, Inc. (TVTX) reported total debt of $15.58M in Q1 2026.
- How has Travere Therapeutics, Inc.'s total debt changed year-over-year?
- Travere Therapeutics, Inc.'s total debt decreased by 82.6% year-over-year, from $89.8M to $15.58M.
- What is the long-term trend for Travere Therapeutics, Inc.'s total debt?
- Over 5 years (2020 to 2025), Travere Therapeutics, Inc.'s total debt has grown at a -13.2% compound annual growth rate (CAGR), from $34.5M to $17.01M.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.
Ask your AI about Travere Therapeutics, Inc.'s total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude